Back to Results
First PageMeta Content
Cancer research / Brain tumor / Experimental cancer treatments / Hepatocellular carcinoma / Prostate cancer / Medicine / Oncology / Hepatology


Targeted agent selumetinib shows promise in biliary cancer
Add to Reading List

Document Date: 2015-02-08 12:40:06


Open Document

File Size: 29,57 KB

Share Result on Facebook

Facility

Ohio State's Comprehensive Cancer Center / Vanderbilt University / The Ohio State University / University of North Carolina / Solove Research Institute / James Cancer Hospital / Emory University / /

IndustryTerm

care for biliary cancers / /

MedicalCondition

tumor / cancer / biliary cancers / tumors / disease / stable disease / such tumors / advanced biliary cancer / biliary cancer / partial tumor / /

Organization

Emory University / Ohio State University / Solove Research Institute / University of North Carolina / The Ohio State University / Vanderbilt University / Ohio State's Comprehensive Cancer Center-James Cancer Hospital / /

Person

Tanios Bekaii-Saab / /

Position

principal investigator / medical director / director of gastrointestinal oncology and a medical oncologist / /

ProvinceOrState

North Carolina / /

PublishedMedium

the Journal of Clinical Oncology / /

URL

http /

SocialTag